These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3103288)

  • 1. Intralymphocytic ionized calcium evaluation in kidney allografts rejection.
    Lamperi S; Carozzi S; Nasini MG; Nocera A; Manca F; Barocci S; Valente U
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1613-7. PubMed ID: 3103288
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of cyclosporine and azathioprine on host cell populations in renal allograft recipients.
    Pullis CK; Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1596-9. PubMed ID: 3547870
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine effect on immunoregulatory cells in kidney transplant recipients: suppression of gamma-interferon and interleukin production.
    Yoshimura N; Kahan BD; Matsui S; Kita M; Hamashima T; Oka T
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):69-74. PubMed ID: 3129846
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 2, interferon, and lymphotoxin in renal transplant recipients.
    McKenna RM; Rush DN; Bakkestad-Legare P; Jeffery JR
    Transplantation; 1988 Jan; 45(1):76-81. PubMed ID: 3122387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal irradiation of the blood. Histological examinations of homografts in patients undergoing immunosuppressive therapy with ECIB before kidney transplantation.
    Weeke E; Henriksen B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):389-96. PubMed ID: 4604467
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of in vivo cyclosporine on interleukin production in kidney transplant recipients.
    Yoshimura N; Oka T; Ohmori Y; Aikawa I; Fukuda M; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1194-8. PubMed ID: 3547855
    [No Abstract]   [Full Text] [Related]  

  • 7. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine experience in renal transplantation in children.
    Tejani A; Butt KM; Khawar MR; Phadke K; Adamson O; Hong J; Fusi M; Trachtman H
    Kidney Int Suppl; 1986 Jul; 19():S38-43. PubMed ID: 3528624
    [No Abstract]   [Full Text] [Related]  

  • 9. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection in kidney transplantation.
    Burgos-Calderon R; Pankey GA; Figueroa JE
    Surgery; 1971 Sep; 70(3):334-40. PubMed ID: 4105515
    [No Abstract]   [Full Text] [Related]  

  • 12. The platelet in the obliterate vascular rejection phenomenon.
    Burrows L; Haimov M; Aledort L; Leiter E; Nirmul G; Shanzer H; Taub R; Glabman S
    Transplant Proc; 1973 Mar; 5(1):157-60. PubMed ID: 4572094
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin A in renal transplantation: a prospective randomized trial.
    Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of clinical transplantation in patients with end-stage renal disease.
    Belzer FO; Kountz SL
    Transplant Proc; 1973 Mar; 5(1):793-7. PubMed ID: 4121182
    [No Abstract]   [Full Text] [Related]  

  • 15. Propagation and characterization of lymphocytes infiltrating renal allografts.
    Bachetoni A; Cinti P; Poli L; Bruzzone P; Alfani D; Molajoni ER; Cortesini R
    Transplant Proc; 1993 Jun; 25(3):2317-9. PubMed ID: 8516914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of immunosuppression with cyclosporin A in cadaveric kidney transplantation].
    Madsen S; Kristensen JK; Langhoff E; Olgaard K; Ladefoged J; Thaysen JH
    Ugeskr Laeger; 1984 Mar; 146(13):951-4. PubMed ID: 6372185
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with fifty human kidney transplants.
    Perdue GD; Smith RB; Lewis EL; Walton KN; Waters WC; Herndon EG
    Am Surg; 1972 Feb; 38(2):74-8. PubMed ID: 4550689
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphokine production in cyclosporine-treated renal transplant recipients.
    McKenna RM; Rush DN; Bakkestad-Legare P; Jeffrey JR
    Transplant Proc; 1988 Dec; 20(6):1245-7. PubMed ID: 3144073
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of corticosteroid therapy for acute renal allograft rejection.
    Vineyard GC; Fadem SZ; Dmochowski J; Carpenter CB; Wilson RE
    Surg Gynecol Obstet; 1974 Feb; 138(2):225-9. PubMed ID: 4589909
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of interleukins during tolerance and rejection of human renal allografts.
    Charpentier B; Lantz O; Lang P; Martin B; Fries D
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1572-3. PubMed ID: 3274385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.